Actor portrayal
NOW APPROVED
Rivfloza™ offers:
aIn children 9 to 11 years of age weighing 110 pounds (50 kilograms) or more, Rivfloza™ may be administered by a health care professional or a caregiver using the pre-filled syringe. In children 9 to 11 years of age weighing less than 110 pounds, Rivfloza™ vials may be administered by a caregiver after proper training, if a health care professional determines that it is appropriate, and with medical follow-up as necessary. Please see Instructions for Use in full Prescribing Information.
For questions about Rivfloza™ or getting started on Rivfloza™, please contact our Customer Care Center: 844-906-5099.
Our NovoCare® patient support team can provide more information about Rivfloza™ and how to get started on treatment. Visit NovoCare® today or contact the NovoCare® team at 844-906-5099.
Rivfloza™ (nedosiran) injection is a new treatment for primary hyperoxaluria type 1 (PH1).
Be among the first to get updates about once-monthly Rivfloza™, including information about our patient support programs, help with the insurance process, and more.